Literature DB >> 23467728

Right ventricular myocardial performance index is decreased with severe pressure-overload cardiac hypertrophy in young rats.

Jeong-Hyeon Ko1, Gwang Hyeon Eom, Hwa Jin Cho, Kwang-Il Nam, Jae Sook Ma, Hyun Kook, Young Kuk Cho.   

Abstract

Although the right ventricular (RV) myocardial performance index (MPI) usually is increased in the presence of RV dysfunction and pressure overload, debate continues over the correlation between the RV MPI and functional derangement in patients with RV pressure-overload congenital heart disease (CHD). To address this controversy, this study took serial measurements of the RV MPI in addition to invasive RV hemodynamic measurements during the acute stage of mild to severe pressure overload. Right ventricle pressure overload was induced by partial pulmonary arterial banding (PAB) in 3-week-old rats. The rats were divided into two groups: mild pulmonary stenosis (PS) group (20-40 % stenosis; n = 20) and severe PS group (40-70 % stenosis; n = 28). Sham-treated animals (sham group; n = 30) underwent the same surgical procedure without PAB. Pressure-overload RV hypertrophy was documented by weighing the heart, by evaluating echocardiograms, and by evaluating cardiac hypertrophy-associated gene expression. The RV MPI was checked 1, 2, 3, 5, and 8 weeks after PAB. The MPI was calculated as the sum of the isovolumic contraction time and the isovolumic relaxation time (IRT) divided by the ejection time. The RV MPI of the mild PS group did not differ significantly from that of the sham group. The RV MPI of the severe PS group, however, was lower than that of the sham group (0.27 ± 0.01 vs 0.29 ± 0.01) 2 to 8 weeks after PAB: 0.19 ± 0.01 at 2 weeks (P < 0.001), 0.16 ± 0.01 at 3 weeks (P < 0.001), 0.20 ± 0.01 at 5 weeks (P = 0.021), and 0.18 ± 0.01 at 8 weeks (P < 0.001) after PAB. The decreased RV MPI was associated with decreased IRT and increased ejection time. RV hypertrophy contributes to the decrease in the RV MPI in the severe pressure-overload condition.

Entities:  

Mesh:

Year:  2013        PMID: 23467728     DOI: 10.1007/s00246-013-0678-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  27 in total

Review 1.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

2.  Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

Authors:  C Tei; R A Nishimura; J B Seward; A J Tajik
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

3.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

4.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.

Authors:  C Tei; K S Dujardin; D O Hodge; R A Kyle; A J Tajik; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

5.  Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats.

Authors:  Young Kuk Cho; Gwang Hyeon Eom; Hae Jin Kee; Hyung-Seok Kim; Woo-Yeon Choi; Kwang-Il Nam; Jae Sook Ma; Hyun Kook
Journal:  Circ J       Date:  2010-03-06       Impact factor: 2.993

6.  Quantitation of the global right ventricular function in children with normal heart and congenital heart disease: a right ventricular myocardial performance index.

Authors:  M Ishii; G Eto; C Tei; T Tsutsumi; K Hashino; Y Sugahara; W Himeno; H Muta; J Furui; T Akagi; R Fukiyama; O Toyoda; H Kato
Journal:  Pediatr Cardiol       Date:  2000 Sep-Oct       Impact factor: 1.655

7.  CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.

Authors:  M M Chen; A Lam; J A Abraham; G F Schreiner; A H Joly
Journal:  J Mol Cell Cardiol       Date:  2000-10       Impact factor: 5.000

8.  Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

Authors:  Hyun Kook; John J Lepore; Aaron D Gitler; Min Min Lu; Wendy Wing-Man Yung; Joel Mackay; Rong Zhou; Victor Ferrari; Peter Gruber; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy.

Authors:  K S Dujardin; C Tei; T C Yeo; D O Hodge; A Rossi; J B Seward
Journal:  Am J Cardiol       Date:  1998-11-01       Impact factor: 2.778

10.  Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study.

Authors:  Ronen Beeri; Chaim Yosefy; J Luis Guerrero; Suzan Abedat; Mark D Handschumacher; Robert E Stroud; Suzanne Sullivan; Miguel Chaput; Dan Gilon; Gus J Vlahakes; Francis G Spinale; Roger J Hajjar; Robert A Levine
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

View more
  2 in total

1.  Clinical Utility of Echocardiography for the Diagnosis and Prognosis in Children with Bronchopulmonary Dsyplasia.

Authors:  Young Earl Choi; Hwa Jin Cho; Eun Song Song; In Seok Jeong; Namsik Yoon; Young Youn Choi; Jae Sook Ma; Young Kuk Cho
Journal:  J Cardiovasc Ultrasound       Date:  2016-12-28

2.  Elabela: A Novel Biomarker for Right Ventricular Pressure Overload in Children With Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum.

Authors:  Jian Wang; Yue Zhou; Qingjie Wang; Bowen Du; Yurong Wu; Qian Chen; Xi Zhang; Yanan Lu; Sun Chen; Kun Sun
Journal:  Front Cardiovasc Med       Date:  2020-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.